Navigation Links
Pandemic vaccination did not increase risk of fetal death
Date:1/17/2013

With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets & therapeutics provides new opportunities for the prevention and treatment of several major disease systems. The 4th Cancer Targets & Therapeutics Conference, taking place on February 25-26, 2013 in Las Vegas, NV will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.

Attendees will learn about:

  • Important progress in key aspects of antibody, vaccine, and cell-based therapies being developed and evaluated in clinical trials for the immunotherapy of cancer

  • How cellular pathways of protein processing and pivotal cell-death pathways are being targeted by new Therapies New therapeutic targets in epigenetic and newly described metabolic pathways that serve as new pathways for drug discovery

  • Advances in targeting angiogenesis

  • Important new animal models for target validation

  • New approaches to drug-conjugates and to dose evaluation for effective therapy

Preliminary Sessions for 2013 Agenda:

  • Novel Kinase Inhibitors & Beyond the Kinome

  • Functional Genomics & Future Cancer targets

  • Novel Antibody-based Modalities

  • Progress in Cancer Immunotherapy

  • Cancer Stem Cells, Metabolism, Cancer Epigenetics

  • Novel Advances & Technologies in Oncology


'/>"/>

Contact: Press Officer
47-210-78300
Norwegian Institute of Public Health
Source:Eurekalert

Page: 1

Related biology news :

1. Improving equine health: Research studies vaccinations to protect newborn foals
2. The effect of treatment with antibiotics and vaccination against Q fever in sheep
3. Teens susceptible to hepatitis B infection despite vaccination as infants
4. Increase in Arctic shipping poses risk to marine mammals
5. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
6. Fertilizer use responsible for increase in nitrous oxide in atmosphere
7. NIST/UMass study finds evidence nanoparticles may increase plant DNA damage
8. Study finds soda consumption increases overall stroke risk
9. Scientists have discovered genes that increase the risk of osteoporosis and fractures
10. Family history of liver cancer increases risk of developing the disease
11. Research shows how PCBs promote dendrite growth, may increase autism risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... for financial services, but it also plays a fundamental part ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
Breaking Biology News(10 mins):
(Date:5/25/2016)... ... May 25, 2016 , ... The American Medical ... Office of the National Coordinator for Health IT (ONC) outlining a measurement approach ... data were available when and where it was needed. The organization of health ...
(Date:5/25/2016)... , ... May 25, 2016 , ... WEDI, the nation’s ... exchange, today announced that Charles W. Stellar has been named by the WEDI Board ... since January 2016. As an executive leader with more than 35 years of experience ...
(Date:5/25/2016)... Connecticut (PRWEB) , ... May 25, 2016 , ... ... the U.S. Food and Drug Administration (FDA) has granted the company’s orphan drug ... the company’s second orphan drug designation granted by the FDA. , Spinocerebellar ...
(Date:5/24/2016)... TEL AVIV, Israel , May 24, 2016   ... on providing physicians with artificial intelligence, real-time decision support tools ... selected to present at the 2016 Israeli Advanced Technology Industries ... part of Israel,s 15th National Life ... to 26th at the David Intercontinental Hotel in ...
Breaking Biology Technology: